Jason Campagna, MD,PhD
Director of Clinical Quality and AnalyticsCottage Health System
Jason Campagna, MD, PhD, is an Anesthesiologist at Anesthesia Medical Group of Santa Barbara in California. He is also Director of Center for Clinical Quality and Analytics at Cottage Health System, an Adjunct Professor of neuroscience and serves as the Director of Center for Applied Neurosciences at the Neuroscience Research Institute at the University of California, Santa Barbara. Dr. Campagna has served as an Attending Anesthesiologist at Massachusetts General Hospital and University of Pennsylvania. His research interests include how anesthetics produce unconsciousness, mechanisms and treatment of acute and neuropathic pain, and physiology and pharmacology of neuromuscular junction. Dr. Campagna has published peer reviewed publications, chapters, and editorials in journals such as New England Journal of Medicine, Anesthesiology, and has edited and contributed to a book on the state of the art in neuromuscular pharmacology and physiology. He has been involved in biotechnology start-up companies in Boston and New York. (This is me - Update Profile)
| 2007 - present | Director of Clinical Quality and Analytics Cottage Health System |
|---|---|
| 2006 - present | Adjunct Professor of Neuroscience University of California, Santa Barbara |
| 2005 - present | Anesthesiologist Anesthesia Medical Group of Santa Barbara, Inc. |
| 2004 - 2005 | Assistant Professor University of Pennsylvania Alumni Club of Philadelphia, Inc. |
| 1998 - 2004 | Attending Anesthesiologist The Massachusetts General Hospital |
GLG Study Groups with Jason Campagna, MD,PhD(?)
| Study Group Name | Members |
|---|---|
| Pain Physicians (US) | 518 |
| Pain Management Anesthesiologists (US) | 256 |
| Critical Care Physicians (US) | 54 |
| Critical Care Physicians | 730 |
GLG NewsSM
Analyses by Jason Campagna, MD,PhD(?)
There are well over 70 Million general anesthetics performed in the US each year, and the majority of these utilize one of four generally used inhaled anesthetic agents (Sevoflurane, Desflurane, Isoflurane and Halothane). How these drugs act to produce "unconsciousness" is largely unknown, but as the...
1. The market for "depth of anesthesia" monitors has depended very much on marketing and public perception of the problem. This article shines a bright light on the more objective issues of utility and efficacy. 2. Aspect Medical has made a number of mis-steps over the years that have alienated them...
The porridge of attention being lavished upon anything related to augmentation of quality and outcomes in medical practice is becoming counterproductive and is obscuring important "currents" of information. To summarize EHR's as offering no benefit is akin to saying that the iphone given to John F Kennedy's...
GLG InstituteSM Seminars with Jason Campagna, MD,PhD(?)
View all GLG InstituteSM Seminars in Healthcare
Request a project with Jason Campagna, MD,PhD
Note: GLG Experts do not provide personal medical advice, diagnosis or treatment through this site.
GLG's 750+ Clients Include:
global mutual funds
global banks
private equity firms

